These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 15621141

  • 1. Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Kamar N, Ribes D, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssiere L, Durand D, Izopet J, Rostaing L.
    Transplant Proc; 2004 Nov; 36(9):2757-61. PubMed ID: 15621141
    [Abstract] [Full Text] [Related]

  • 2. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Kamar N, Borde JS, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssière L, Durand D, Izopet J, Rostaing L.
    Clin Transplant; 2005 Feb; 19(1):83-9. PubMed ID: 15659139
    [Abstract] [Full Text] [Related]

  • 3. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD, Loss GE, Blazek J, Nair S, Mason AL.
    Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
    [Abstract] [Full Text] [Related]

  • 4. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 5. Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection.
    Nair S, Loss GE, Cohen AJ, Eason JD.
    Transplantation; 2006 Feb 27; 81(4):620-2. PubMed ID: 16495812
    [Abstract] [Full Text] [Related]

  • 6. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.
    Liver Transpl; 2004 Mar 27; 10(3):404-7. PubMed ID: 15004768
    [Abstract] [Full Text] [Related]

  • 7. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L, Kamar N, Durand D, Rostaing L.
    Transplant Proc; 2005 Mar 27; 37(2):892-4. PubMed ID: 15848567
    [Abstract] [Full Text] [Related]

  • 8. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 27; 37(4):1700-2. PubMed ID: 15919436
    [Abstract] [Full Text] [Related]

  • 9. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ.
    Liver Transpl; 2003 Mar 27; 9(3):239-47. PubMed ID: 12619020
    [Abstract] [Full Text] [Related]

  • 10. Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation.
    Shah A, Agarwal A, Mangus R, Lim J, Fridell J, Vianna R, Tector AJ.
    Liver Transpl; 2006 Aug 27; 12(8):1210-4. PubMed ID: 16868953
    [Abstract] [Full Text] [Related]

  • 11. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
    Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE.
    Transplantation; 2003 Apr 27; 75(8):1396-9. PubMed ID: 12717237
    [Abstract] [Full Text] [Related]

  • 12. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.
    Pharmacotherapy; 2009 Oct 27; 29(10):1166-74. PubMed ID: 19792990
    [Abstract] [Full Text] [Related]

  • 13. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F, Di Sandro S, De Ruvo N, Berretta M, Montalti R, Guerrini GP, Ballarin R, De Blasiis MG, Spaggiari M, Smerieri N, Iemmolo RM, Guaraldi G, Gerunda GE.
    Transplant Proc; 2008 Oct 27; 40(6):1965-71. PubMed ID: 18675102
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chen J, Tector AJ.
    Liver Transpl; 2012 Jul 27; 18(7):786-95. PubMed ID: 22237953
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.
    Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986
    [Abstract] [Full Text] [Related]

  • 16. High dose rabbit antithymocyte globulin induction in living related liver transplantation.
    Masetti M, Montalti R, Arpinati M, Di Benedetto F, Miller CM, Zagnoli A, De Ruvo N, Guerrini GP, Romano A, Rondelli D, Chirumbolo G, Rompianesi G, Pinna AD, Gerunda GE.
    Hepatogastroenterology; 2007 Jan 27; 54(75):884-8. PubMed ID: 17591084
    [Abstract] [Full Text] [Related]

  • 17. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G, Fernandez LA, Knechtle SJ, D'Alessandro AM, Chin LT, Musat AI, Lucey MR, Said A, Pirsch JD, Leverson G, Kalayoglu M.
    Transplant Proc; 2008 Jan 27; 40(1):219-23. PubMed ID: 18261591
    [Abstract] [Full Text] [Related]

  • 18. Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation.
    De Ruvo N, Cucchetti A, Lauro A, Masetti M, Cautero N, Di Benedetto F, Dazzi A, Del Gaudio M, Ravaioli M, Zanello M, La Barba G, di Francesco F, Risaliti A, Ramacciato G, Pinna AD.
    Transplant Proc; 2005 Jan 27; 37(6):2607-8. PubMed ID: 16182760
    [Abstract] [Full Text] [Related]

  • 19. Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients.
    Yoo MC, Vanatta JM, Modanlou KA, Campos L, Nezakatgoo N, Nair S, Eason JD.
    Transplantation; 2015 Jun 27; 99(6):1231-5. PubMed ID: 25539464
    [Abstract] [Full Text] [Related]

  • 20. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F.
    Transplantation; 2008 Dec 27; 86(12):1666-71. PubMed ID: 19104402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.